Union Square Park Capital Management LLC Has $7.37 Million Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Union Square Park Capital Management LLC lifted its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 47.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 160,000 shares of the company's stock after acquiring an additional 51,192 shares during the period. Establishment Labs makes up 4.8% of Union Square Park Capital Management LLC's holdings, making the stock its 6th biggest holding. Union Square Park Capital Management LLC owned 0.57% of Establishment Labs worth $7,371,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in ESTA. Quarry LP bought a new position in shares of Establishment Labs during the 4th quarter valued at approximately $27,000. R Squared Ltd bought a new position in shares of Establishment Labs during the 4th quarter valued at approximately $36,000. KLP Kapitalforvaltning AS bought a new position in shares of Establishment Labs during the 4th quarter valued at approximately $161,000. Hood River Capital Management LLC grew its position in shares of Establishment Labs by 236.4% during the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company's stock valued at $273,000 after acquiring an additional 4,160 shares during the period. Finally, Handelsbanken Fonder AB lifted its stake in shares of Establishment Labs by 32.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after buying an additional 2,000 shares in the last quarter. 72.91% of the stock is owned by institutional investors.

Establishment Labs Stock Performance

Shares of ESTA traded down $0.23 during mid-day trading on Friday, hitting $36.62. 306,871 shares of the company traded hands, compared to its average volume of 473,448. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. The stock has a 50-day moving average price of $34.33 and a two-hundred day moving average price of $37.88. Establishment Labs Holdings Inc. has a 1 year low of $26.56 and a 1 year high of $58.00. The stock has a market cap of $1.06 billion, a price-to-earnings ratio of -14.19 and a beta of 0.73.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported ($0.70) EPS for the quarter, beating analysts' consensus estimates of ($0.83) by $0.13. The business had revenue of $41.38 million during the quarter, compared to analysts' expectations of $41.15 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The firm's revenue was up 11.3% on a year-over-year basis. During the same period in the prior year, the company earned ($0.58) earnings per share. Equities analysts anticipate that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on ESTA. Needham & Company LLC upgraded shares of Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price target on the stock in a research note on Wednesday, May 14th. Stephens reissued an "overweight" rating and issued a $52.00 price target on shares of Establishment Labs in a report on Thursday, March 6th. BTIG Research initiated coverage on shares of Establishment Labs in a research report on Friday, May 16th. They set a "buy" rating and a $62.00 price target for the company. Finally, Wall Street Zen cut shares of Establishment Labs from a "hold" rating to a "sell" rating in a research report on Thursday. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $55.33.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.